Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 2, 2025 Off

Ostro Named to Inc.’s 2025 Best in Business List for Best AI Implementation

By BusinessWire

The annual list recognizes the industry-leading companies that are the best at what they do NEW YORK–(BUSINESS WIRE)–Ostro, the leader…

December 2, 2025 Off

GE HealthCare introduces advanced imaging solutions powered by NVIDIA technology to support timely diagnoses and streamlined clinical workflows

By BusinessWire

NVIDIA technology is now integrated into several of GE HealthCare’s new imaging solutions, including Photonova Spectra1, SIGNA Sprint with Freelium2,…

December 2, 2025 Off

Curi Bio Secures $10M Series B to Scale Human-Relevant Preclinical Platforms and Advanced Data Analysis for Drug Discovery

By BusinessWire

Financing led by DreamCIS will accelerate and expand development of the company’s industry-leading integrated platform, combining human iPSC-derived cells, advanced…

December 2, 2025 Off

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

By BusinessWire

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules…

December 2, 2025 Off

Peapod Bio Inc. and Enamine Ltd. Announce Strategic Collaboration

By BusinessWire

Partnership unites advanced screening solutions with world-class small molecule libraries. CHICAGO–(BUSINESS WIRE)–#AssayDevelopment—Peapod Bio Inc., a leader in innovative assay development…

December 2, 2025 Off

Laxxon Medical’s Innovative Levodopa / Carbidopa (LXM.5) Oral Dosage Form Demonstrates Significantly Higher Bioavailability (>380%) Compared to Sinemet®, Study Results Published in the Journal Pharmaceutics

By BusinessWire

SPID®-Technology utilizes compartmentalization to enable sequential release of carbidopa and levodopa, offering a potential new approach for drug delivery in…

December 2, 2025 Off

Archeus Technologies Doses First Patient with ART-101 in Phase 1 Prostate Cancer Study

By BusinessWire

MADISON, Wis.–(BUSINESS WIRE)–Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies for the treatment of patients with cancer, today announced…

December 2, 2025 Off

Unravel Biosciences Announces Approval by Colombian Health Regulatory Authority to Initiate RVL-001 Clinical Studies for Rett Syndrome and Pitt Hopkins Syndrome

By BusinessWire

Study approval enables Rett REVOLUTION and Pitt Hopkins clinical programs to commence patient recruitment with first dosing expected in January…

December 2, 2025 Off

Findings from Ontada’s Real-World Study: Maintaining Hemoglobin Levels >10 g/dL in Patients with Myelodysplastic Syndrome is Associated with Significantly Improved Overall Survival

By BusinessWire

Results of Ontada study to be presented at ASH signals a need to revisit anemia strategies in patients with myelodysplastic…

December 2, 2025 Off

Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System

By BusinessWire

LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the…

Posts pagination

Previous 1 … 9 10 11 … 6,180 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

December 5, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine